Table 2.
Main MR results and sensitivity analyses for the bidirectional relationships of physical activity and sedentary behaviour with mental health and substance use disorders.
Direction 1: Physical activity/sedentary behaviour -> Mental health/substance use disorders | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Outcome | Exposure | MR method | N (snps) | b | SE | CI (lower) | CI (upper) | P-value (raw) |
P-value (FDR-adjusted) |
Odds ratioa/Standardised effectb |
Depression | Accelerometer-based PA, mean acceleration (G1) | IVW | 7 | −0.043 | 0.014 | −0.071 | −0.016 | 0.002 | 0.040 | 0.957a |
Egger | 7 | −0.115 | 0.067 | −0.246 | 0.016 | 0.145 | 0.812 | 0.891a | ||
Weighted median | 7 | −0.039 | 0.023 | −0.084 | 0.006 | 0.089 | 0.584 | 0.962a | ||
Weighted mode | 7 | −0.065 | 0.036 | −0.137 | 0.006 | 0.123 | 0.913 | 0.937a | ||
Schizophrenia | Accelerometer-based sedentary behaviour (G1) | IVW | 3 | −0.230 | 0.028 | −0.285 | −0.175 | 0.000 | 0.000 | 0.795a |
Egger | 3 | −0.079 | 0.893 | −1.829 | 1.671 | 0.944 | 0.984 | 0.924a | ||
Weighted median | 3 | −0.217 | 0.198 | −0.605 | 0.171 | 0.273 | 0.744 | 0.805a | ||
Weighted mode | 3 | −0.202 | 0.222 | −0.636 | 0.232 | 0.458 | 0.913 | 0.817a | ||
Schizophrenia | Accelerometer-based sedentary behaviour (G2) | IVW | 53 | −0.260 | 0.087 | −0.431 | −0.089 | 0.003 | 0.045 | 0.771a |
Egger | 53 | −0.362 | 0.268 | −0.887 | 0.162 | 0.182 | 0.812 | 0.696a | ||
Weighted median | 53 | −0.207 | 0.079 | −0.362 | −0.052 | 0.009 | 0.186 | 0.813a | ||
Weighted mode | 53 | −0.227 | 0.137 | −0.496 | 0.042 | 0.104 | 0.913 | 0.797a | ||
RAPS | 53 | −0.259 | 0.047 | −0.351 | −0.166 | 0.000 | 0.000 | 0.772a | ||
Schizophrenia | Accelerometer-based walking (G1) | Wald ratio | 1 | −0.998 | 0.322 | −1.629 | −0.368 | 0.002 | 0.040 | 0.368a |
Anorexia | Accelerometer-based sedentary behaviour (G2) | IVW | 51 | −0.341 | 0.096 | −0.530 | −0.152 | 0.000 | 0.014 | 0.711a |
Egger | 51 | −0.797 | 0.360 | −1.503 | −0.090 | 0.032 | 0.555 | 0.451a | ||
Weighted median | 51 | −0.278 | 0.136 | −0.546 | −0.011 | 0.041 | 0.351 | 0.757a | ||
Weighted mode | 51 | −0.287 | 0.281 | −0.838 | 0.264 | 0.313 | 0.913 | 0.751a | ||
RAPS | 52 | −0.280 | 0.086 | −0.448 | −0.111 | 0.001 | 0.012 | 0.756a | ||
ADHD | Self-reported moderate-vigorous PA (G2) | IVW | 100 | 0.525 | 0.171 | 0.189 | 0.860 | 0.002 | 0.040 | 1.690a |
Egger | 100 | −0.517 | 0.716 | −1.920 | 0.885 | 0.471 | 0.812 | 0.596a | ||
Weighted median | 100 | 0.243 | 0.188 | −0.125 | 0.611 | 0.195 | 0.744 | 1.275a | ||
Weighted mode | 100 | 0.152 | 0.478 | −0.786 | 1.090 | 0.751 | 0.913 | 1.164a | ||
RAPS | 100 | 0.545 | 0.120 | 0.310 | 0.780 | 0.000 | 0.000 | 1.725a | ||
Cigarette Smoking | Accelerometer-based PA, mean acceleration (G1) | IVW | 6 | −0.026 | 0.005 | −0.035 | −0.017 | 0.000 | 0.000 | −0.022b |
Egger | 6 | −0.039 | 0.030 | −0.097 | 0.019 | 0.261 | 0.812 | −0.005b | ||
Weighted median | 6 | −0.022 | 0.009 | −0.040 | −0.004 | 0.018 | 0.276 | −0.010b | ||
Weighted mode | 6 | −0.021 | 0.012 | −0.044 | 0.003 | 0.145 | 0.913 | −0.007b |
Direction 2: Mental health/substance use disorders -> Physical activity/sedentary behaviour | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Exposure | Outcome | MR method | N (snps) | b | SE | CI (lower) | CI (upper) | P-value (raw) |
P-value (FDR-adjusted) |
Standardised effect |
PTSD | Self-reported moderate-vigorous PA (G2) | IVW | 220 | 0.022 | 0.006 | 0.009 | 0.034 | 0.001 | 0.009 | 0.005 |
Egger | 220 | −0.012 | 0.027 | −0.065 | 0.041 | 0.659 | 0.998 | −0.001 | ||
Weighted median | 220 | 0.025 | 0.007 | 0.011 | 0.039 | 0.001 | 0.020 | 0.005 | ||
Weighted mode | 220 | 0.048 | 0.026 | −0.002 | 0.098 | 0.063 | 0.872 | 0.003 | ||
RAPS | 220 | 0.024 | 0.005 | 0.015 | 0.033 | 0.000 | 0.000 | 0.007 | ||
Bipolar disorder | Accelerometer-based moderate PA (G1) | IVW | 52 | 0.043 | 0.013 | 0.017 | 0.068 | 0.001 | 0.010 | 0.016 |
Egger | 52 | 0.139 | 0.063 | 0.015 | 0.263 | 0.033 | 0.796 | 0.011 | ||
Weighted median | 52 | 0.038 | 0.016 | 0.006 | 0.070 | 0.021 | 0.236 | 0.011 | ||
Weighted mode | 52 | 0.048 | 0.037 | −0.024 | 0.120 | 0.198 | 0.872 | 0.006 | ||
Bipolar disorder | Accelerometer-based moderate PA (G2) | IVW | 234 | 0.024 | 0.007 | 0.011 | 0.037 | 0.000 | 0.006 | 0.018 |
Egger | 234 | 0.022 | 0.023 | −0.024 | 0.068 | 0.345 | 0.998 | 0.005 | ||
Weighted median | 234 | 0.027 | 0.009 | 0.008 | 0.045 | 0.005 | 0.082 | 0.014 | ||
Weighted mode | 234 | 0.042 | 0.028 | −0.012 | 0.096 | 0.133 | 0.872 | 0.007 | ||
RAPS | 234 | 0.027 | 0.006 | 0.015 | 0.040 | 0.000 | 0.000 | 0.021 | ||
Bipolar disorder | Accelerometer-based sedentary behaviour (G2) | IVW | 234 | −0.026 | 0.008 | −0.041 | −0.011 | 0.001 | 0.009 | −0.017 |
Egger | 234 | −0.016 | 0.027 | −0.070 | 0.038 | 0.565 | 0.998 | −0.003 | ||
Weighted median | 234 | −0.013 | 0.010 | −0.032 | 0.006 | 0.176 | 0.742 | −0.007 | ||
Weighted mode | 234 | 0.014 | 0.029 | −0.042 | 0.070 | 0.619 | 0.872 | 0.002 | ||
RAPS | 234 | −0.027 | 0.006 | −0.039 | −0.014 | 0.000 | 0.000 | −0.021 | ||
Schizophrenia | Accelerometer-based moderate PA (G2) | IVW | 424 | 0.018 | 0.003 | 0.011 | 0.024 | 0.000 | 0.044 | 0.014 |
Egger | 424 | 0.024 | 0.012 | 0.002 | 0.047 | 0.035 | 0.998 | 0.004 | ||
Weighted median | 424 | 0.013 | 0.004 | 0.006 | 0.021 | 0.001 | 0.215 | 0.012 | ||
Weighted mode | 424 | 0.009 | 0.013 | −0.017 | 0.035 | 0.511 | 0.872 | 0.006 | ||
RAPS | 424 | 0.018 | 0.002 | 0.014 | 0.023 | 0.000 | 0.021 | 0.014 | ||
Schizophrenia | Accelerometer-based sedentary behaviour (G2) | IVW | 424 | −0.023 | 0.006 | −0.035 | −0.011 | 0.000 | 0.006 | −0.018 |
Egger | 424 | −0.023 | 0.022 | −0.066 | 0.021 | 0.309 | 0.998 | −0.005 | ||
Weighted median | 424 | 0.002 | 0.008 | −0.013 | 0.018 | 0.777 | 0.944 | 0.001 | ||
Weighted mode | 424 | 0.018 | 0.021 | −0.023 | 0.060 | 0.388 | 0.872 | 0.004 | ||
RAPS | 424 | −0.022 | 0.005 | −0.031 | −0.012 | 0.000 | 0.000 | −0.021 | ||
Schizophrenia | Self-reported moderate-vigorous PA (G1) | IVW | 196 | 0.017 | 0.005 | 0.008 | 0.026 | 0.000 | 0.004 | 0.009 |
Egger | 196 | 0.021 | 0.018 | −0.015 | 0.057 | 0.255 | 0.998 | 0.003 | ||
Weighted median | 196 | 0.009 | 0.005 | −0.001 | 0.018 | 0.076 | 0.685 | 0.004 | ||
Weighted mode | 196 | −0.002 | 0.013 | −0.027 | 0.024 | 0.883 | 0.935 | −0.000 | ||
Schizophrenia | Self-reported moderate-vigorous PA (G2) | IVW | 424 | 0.018 | 0.003 | 0.011 | 0.024 | 0.000 | 0.000 | 0.013 |
Egger | 424 | 0.024 | 0.012 | 0.002 | 0.047 | 0.035 | 0.796 | 0.005 | ||
Weighted median | 424 | 0.013 | 0.004 | 0.006 | 0.021 | 0.001 | 0.020 | 0.008 | ||
Weighted mode | 424 | 0.009 | 0.013 | −0.017 | 0.035 | 0.511 | 0.872 | 0.002 | ||
RAPS | 424 | 0.018 | 0.002 | 0.014 | 0.023 | 0.000 | 0.000 | 0.018 | ||
Anorexia | Self-reported moderate-vigorous PA (G1) | IVW | 6 | 0.061 | 0.009 | 0.042 | 0.079 | 0.000 | 0.000 | 0.015 |
Egger | 6 | 0.051 | 0.037 | −0.021 | 0.124 | 0.238 | 0.998 | 0.003 | ||
Weighted median | 6 | 0.065 | 0.015 | 0.035 | 0.094 | 0.000 | 0.001 | 0.010 | ||
Weighted mode | 6 | 0.071 | 0.022 | 0.029 | 0.114 | 0.021 | 0.872 | 0.008 | ||
ADHD | Self-reported moderate-vigorous PA (G2) | IVW | 73 | 0.017 | 0.005 | 0.007 | 0.027 | 0.001 | 0.009 | 0.008 |
Egger | 73 | 0.015 | 0.018 | −0.020 | 0.049 | 0.405 | 0.998 | 0.002 | ||
Weighted median | 73 | 0.008 | 0.006 | −0.004 | 0.020 | 0.191 | 0.742 | 0.003 | ||
Weighted mode | 73 | −0.006 | 0.015 | −0.036 | 0.024 | 0.691 | 0.899 | −0.001 | ||
RAPS | 73 | 0.013 | 0.004 | 0.006 | 0.020 | 0.000 | 0.003 | 0.009 | ||
Autism | Accelerometer-based walking (G1) | IVW | 2 | −0.122 | 0.021 | −0.164 | −0.081 | 0.000 | 0.000 | −0.027 |
Only IVW/Wald ratio estimates with a FDR-adjusted p < 0.05 are presented in the table (the full MR results for all associations are reported in Appendix 2); alternative MR methods are not available for instruments including less than 3 SNPs; as effect size measures, odds ratios are reported for binary outcomes and standardised beta coefficients for continuous outcomes;
MR Mendelian randomisation, IVW inverse variance weighted, RAPS Robust adjusted profile score, CI confidence interval, FDR false discovery rate, PA physical activity;
G1 = genome-wide significant genetic instrument (P < 5 × 10 − 8), G2 = more relaxed genetic instrument (P < 1 × 10 − 6).
aOdds ratio.
bstandardised effect size.
Bold values indicate MR effects with a p-value < 0.05.